Detalhe da pesquisa
1.
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.
Cancer Immunol Immunother
; 72(3): 579-589, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989364
2.
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.
BMC Immunol
; 22(1): 38, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144673
3.
Targeting two radiation-induced immunosuppressive pathways to improve the efficacy of normofractionated radiation therapy in a preclinical colorectal cancer model.
Int J Radiat Biol
; 100(6): 912-921, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506658
4.
Chemotherapy to potentiate the radiation-induced immune response.
Int Rev Cell Mol Biol
; 376: 143-173, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997268
5.
Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4 + Th1 Response in Metastatic Non-Small Cell Lung Cancer.
J Immunother
; 46(7): 279-283, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799899
6.
TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition.
Front Immunol
; 13: 932298, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935946
7.
Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies.
Cancers (Basel)
; 13(19)2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638376
8.
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230108